Status | Study |
Completed |
Study Name: Aberrations in Carnitine Homeostasis in Congenital Heart Disease With Increased Pulmonary Blood Flow Condition: Heart Septal Defects, Ventricular Atrioventricular Septal Defec Date: 2013-03-28 Interventions: Drug: IV L-carnitine See arm description |
Completed |
Study Name: Right Bundle Branch Block After Surgical Closure of Ventricular Septal Defect Condition: Bundle-Branch Block Heart Septal Defects, Ventricular Date: 2011-11-16 Interventions: Procedure: Echocardiography at rest |
Completed |
Study Name: The Effect of Remote Ischemic Preconditioning on the Ischemic Reperfusion Injury in Infants With Ventricular Septal Defect and Pulmonary Hypertension Condition: Ventricular Septal Defect Pulmonary Hypertension Date: 2011-03-10 Interventions: Other: remote ischemic preconditioning (RIPC) RIPC will be performed by 5-min cycles of lower limb ische |
Completed |
Study Name: Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol Condition: Atrial Septal Defect Ventricular Septal Defect Date: 2010-05-06 Interventions: Drug: Intravenous L-Citrulline |
Completed |
Study Name: Transcatheter Closure Versus Surgery of Perimembranous Ventricular Septal Defects Condition: Ventricular Septal Defects Date: 2009-04-23 Interventions: Device: Shanghai pmVSD occluder |
Completed |
Study Name: Measures to Lower the Stress Response in Pediatric Cardiac Surgery Condition: Tetralogy of Fallot Ventricular Septal Defects Date: 2009-02-19 Interventions: Drug: Fentanyl 25 mcg/kg in tw |
Recruiting |
Study Name: Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study Condition: Ventricular Septal Defects Date: 2008-03-27 Interventions: Device: Muscular VSD Occluder device implantation (AMPLATZER Muscular VSD Occluder) Device |
Completed |
Study Name: Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDER Condition: Membranous Ventricular Septal Defects Date: 2007-12-20 Interventions: Device: AMPLATZER Membranous VSD Occluder Device closure with the AMPLATZER Membranous VSD Occluder |
Completed |
Study Name: Use of Ketamine Prior to Cardiopulmonary Bypass in Children Condition: Ventricular Septal Defect Date: 2007-11-09 Interventions: Drug: saline 2 mg/Kg IV saline |
Suspended |
Study Name: Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System Condition: Heart Septal Defects, Ventricular Date: 2006-10-19 Interventions: Device: transcatheter implantation of a VSD occluder (Nitinol coil) transcatheter implantation, by first |